New cancer clinical trial: Phase 1 Clinical Trial to Evaluate the Safety of Allogeneic NK Cell ("SMT-NK") Cell Therapy in Advanced Biliary Tract Cancer

Published on: December 01, 2017 at 10:00AM
Condition:   Advanced Biliary Tract Cancer
Intervention:   Biological: Natural killer cell
Sponsor:   Yonsei University
Recruiting
http://ift.tt/2zXZzRT